Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

53.85% (1Y)

Market Cap	11.96B
Revenue (ttm)	4.47B
Net Income (ttm)	-1.70B
Shares Out	4.27B
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	619,715
Average Volume	634,074
Open	n/a
Previous Close	2.800
Day's Range	n/a
52-Week Range	1.510 - 3.800
Beta	0.29
RSI	44.58
Earnings Date	Apr 30, 2025

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments. The company was formally known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated...

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 202
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.47 billion, an increase of 102.23% compared to the previous year's 2.21 billion. Losses were -1.70 billion, -40.70% less than in 2023.